Headington, Oxford, OX3 7LD) This is a large subject and it is therefore necessary to be selective. I will not deal with the recent work on calcitonin and parathyroid hormone, and my approach will be fairly clinical. We must consider the 'classical' metabolic disorders of bone (osteoporosis, osteomalacia, osteitis fibrosa cystica and Paget's disease) but not forget such disorders as osteogenesis imperfecta and homocystinuria which emphasize the importance of the bone matrix.
ADVANCES IN UNDERSTANDING
Clinical Osteoporosis: Although some may rightly consider the senile form to be a physiological change (Newton-John & Morgan 1968) , the acute idiopathic juvenile type is certainly pathological (Dent & Friedman 1965) . This condition may be more common than we realize; it can remain undiagnosed or be diagnosed in error as, for instance, a form of osteogenesis imperfecta. It appears to occur in an attack which is self-limiting and unaffected by treatment -features which are less obvious but probably true of the adult form (Dent & Watson 1966) .
Osteomalacia: The known types are increasing and have recently been reviewed (Dent 1969 (Dent & Smith 1969) . The diagnostic significance of proximal muscle weakness has been re-emphasized (Smith & Stern 1967 and also its importance in our understanding of the action of vitamin D (see below). This weakness also occurs in the new disorder 'dialysis bone disease' which has other features remarkably like acute osteoporosis. Its cause is unknown.
Hyperparathyroidism: Studies of numerous cases have strongly supported the idea that transformation from parathyroid hyperplasia (secondary to malabsorption or renal disease) to the autonomous adenoma of so-called 'tertiary' hyperparathyroidism (Davies et al. 1968) (Smith & Stern 1967 (Zorab 1968) . However, there is an occasional outstanding advance; one of these was the recognition and investigation of homocystinuria (Cusworth & Dent 1969 (Goodman et al. 1968 ). However, we may be quite wrong to consider that the bone changes are due to a disorder of collagen matrix since glycoproteins (Andrews et al. 1969 ) may control the orientation and laying down of collagen. Biochemical I have selected three topics for discussion.
Collagen and hydroxyproline: More than half the collagen in the body is in the bone matrix and this collagen is metabolically much more active than, for instance, that in the skin. Collagen is a unique protein which contains two particular aminoacids, hydroxyproline and hydroxylysine. The hydroxylation of proline and lysine probably occurs after the peptide chain is formed. Hydroxyproline (and hydroxylysine) is not re-incorporated into the amino-acidpool when collagen is broken down and a proportion is excreted in the urine. The evidence that the urinary total hydroxyproline (THP) -free and peptide bound -reflects the activity of bone collagen has been extensively reviewed (Prockop & Kivirikko 1967) . Whether or not it represents formation or resorption depends on the particular clinical situation. For our purpose the word 'turnover' is adequate.
Measurement of THP excretion has been useful in a number of conditions:
(1) It is high where there is increased bone 'turnover'. Thus, in active Paget's disease or in generalized osteitis fibrosa it may increase up to 1,000 mg a day (normal upper limit on low gelatin diet approximately 50 mg per day). It is normal in hyperparathyroidism without radiological bone disease and in osteoporosis, and low in scurvy and myxcedema.
(2) If a patient with osteomalacia is given vitamin D there is a temporary increase in THP excretion. The increase affects only the peptide-bound hydroxyproline and has been thought to demonstrate a direct action ofvitamin D on rachitic bone (Smith & Dick 1968a, b (Smith 1969) ; this coincides with the sudden cessation of bone resorption, the disappearance of bone pain and the rapid decline in parathyroid hormone levels. The subsequent biochemical events may be complex, especially ifvitamin D is given.
(5) The profound effect of growth hormone on bone can be shown by the rapid increase of THP excretion when a pituitary dwarf is given growth hormone (Smiley & Ziff 1964) . Thyroxine also directly affects bone mineral and matrix, and the THP excretion increases when a hypothyroid patient is given thyroxine or triiodothyronine. This is mainly due to increased bone matrix resorption (Prockop & Kivirikko 1967) . (6) In most conditions with an increased THP excretion the hydroxyproline is in the form of small peptides. We (Cahill et al. 1970 ) and others (Anderson et al. 1967 ) have identified and isolated a number of these.
There are also large collagen-derived peptides which are virtually non-dialysable, of molecular weight approximately 10,000. These have been described in Paget's disease (Krane etal. 1967 (Smith & Stern 1967 Muscle depends for its contraction on the availability of calcium (Ebashi & Endo 1968) which is controlled by the action of the sarcoplasmic reticulum (Huxley 1969) , and it is not impossible that mechanisms similar to those in the intestine exist for calcium transport in muscles.
Phosphonates: One of the potentially most exciting advances in metabolic bone disease has come from the study of the role of pyrophosphate in calcification. Dr Graham Russell and Dr Fleisch and their associates have been investigating new compounds called phosphonates. These are a series of compounds with a P-C-P bond which is resistant to the action of naturally occurring pyrophosphatases and phosphatases. Experimentally they prevent metastatic calcification and immobilization osteoporosis in animals, and they may be of use in myositis ossificans progressiva (Ryan et al. 1969) .
Homocystinuria: In a proportion of cases the measured biochemical abnormalities may be corrected by giving pyridoxine in large doses.
Whether this has any effect on the course of the disease and the skeletal changes will be difficult to prove, since some patients with homocystinuria are in any case physically normal. Pyridoxine (and aspirin) may reduce platelet stickiness and hence post-operative thromboses.
In bone disorders presumed to be due to disorders of bone matrix, there is little advance in management. In osteogenesis imperfecta the suggestion that there may, in addition, be a defect of mineralization (Solomons & Styner 1969) is not, at present, clinically helpful.
Finally, marble bone disease, osteopetrosis, requires brief mention. In this condition, which may present as a severe form in infancy or as a mild form in adult life, the spontaneous variation which occurs in bone density suggested to Dent and his associates that, whatever the underlying defect, the laying down of excessively dense bone can be influenced by external factors. They subsequently showed that an infant with the severe form of marble bone disease would produce radiologically normal bone when virtually deprived of oral calcium.
Future work should tell us a lot more about bone matrix and vitamin D, and the rapid development of substances capable of checking bone resorption and metastaticcalcification could transform the therapeutic field. As far as this Section is concernedthemain and most important advances should come in diagnosis.
